Search Results - "Haegele, K D"

Refine Results
  1. 1

    Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans by Dow, J, Piriou, F, Wolf, E, Dulery, B D, Haegele, K D

    Published in Drug metabolism and disposition (01-09-1994)
    “…Mofegiline or MDL 72,974A ((E)-4-fluoro-beta-fluoromethylene benzene butanamine hydrochloride) is a selective enzyme-activated irreversible inhibitor of…”
    Get more information
    Journal Article
  2. 2

    Analysis of 2-difluoromethyl- dl-ornithine in human plasma, cerebrospinal fluid and urine by cation-exchange high-performance liquid chromatography by Huebert, N.D., Schwartz, J.-J., Haegele, K.D.

    Published in Journal of Chromatography A (21-02-1997)
    “…An analytical method has been developed based on cation-exchange liquid chromatography for the measurement of 2-difluoromethyl- dl-ornithine (DFMO) in human…”
    Get full text
    Journal Article Conference Proceeding
  3. 3
  4. 4

    Cardioselectivity of alpha-tocopherol analogues, with free radical scavenger activity, in the rat by Dow, J, Petty, M A, Grisar, J M, Wagner, E R, Haegele, K D

    Published in Drug metabolism and disposition (01-11-1991)
    “…MDL74270 (6-acetyloxy-3,4-dihydro-N,N,N,2,5,7, 8-heptamethyl-2H-1-benzopyran-2-ethanaminium, 4-methylbenzenesulfonate) is a quaternary amine analogue of…”
    Get more information
    Journal Article
  5. 5

    Cerebrospinal fluid parameters in healthy volunteers during serial lumbar punctures by Ben Menachem, E, Persson, L, Schechter, P J, Haegele, K D, Huebert, N, Hardenberg, J

    Published in Journal of neurochemistry (01-02-1989)
    “…Lumbar punctures were performed on four occasions over a 5-day period (8:30 a.m. on days 1, 3, and 5; 2:30 p.m. on day 2) on 10 normal volunteers (five of each…”
    Get more information
    Journal Article
  6. 6

    Metabolism and pharmacokinetics of the cardiotonic agent piroximone and of its major metabolite in dog by Berg-Candolfi, M, Dulery, B, Jehl, F, Haegele, K D

    Published in Xenobiotica (01-01-1995)
    “…1. Piroximone was administered orally (p.o.) and intravenously (i.v.) to male Beagle dog. In vitro, piroximone was incubated with dog liver microsomes. 2…”
    Get more information
    Journal Article
  7. 7

    The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients by Ben‐Menachem, E, Persson, LI, Schechter, PJ, Haegele, KD, Huebert, N, Hardenberg, J, Dahlgren, L, Mumford, JP

    Published in British journal of clinical pharmacology (01-01-1989)
    “…1. Vigabatrin, 50 mg kg‐1, was administered orally as add‐on therapy to 11 patients with drug‐resistant complex partial epilepsy as a single dose, then once…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer by Haegele, K D, Schechter, P J

    Published in Clinical pharmacology and therapeutics (01-11-1986)
    “…Six healthy men received single oral doses of 1500 mg of vigabatrin [(R,S)-gamma-vinyl-GABA] and 750 mg of S(+)-gamma-vinyl-GABA on two occasions…”
    Get more information
    Journal Article
  10. 10

    Pharmacokinetics of vigabatrin: implications of creatinine clearance by Haegele, K D, Huebert, N D, Ebel, M, Tell, G P, Schechter, P J

    Published in Clinical pharmacology and therapeutics (01-11-1988)
    “…The pharmacokinetics of both enantiomers of vigabatrin after a single oral dose in healthy young subjects (mean creatinine clearance 120 ml/min) were compared…”
    Get more information
    Journal Article
  11. 11

    Review: Normal and abnormal central nervous system GABA metabolism in childhood by Jaeken, J., Casaer, P., Haegele, K. D., Schechter, P. J.

    Published in Journal of inherited metabolic disease (01-11-1990)
    “…Summary The metabolism and function of central nervous system GABA is briefly reviewed. Hereditary disorders of the GABA metabolism presenting in childhood are…”
    Get full text
    Journal Article
  12. 12

    2-Pyrrolidinone in human cerebrospinal fluid: a major constituent of total gamma-aminobutyric acid by Haegele, K D, Schwartz, J J, Schoun, J, Schmitt, A H, Schechter, P J

    Published in Journal of neurochemistry (01-11-1987)
    “…2-Pyrrolidinone, the lactam of gamma-aminobutyric acid (GABA), is identified as the major constituent of total GABA in human CSF. Structural elucidation was…”
    Get more information
    Journal Article
  13. 13

    Treatment of human late stage gambiense trypanosomiasis with alpha-difluoromethylornithine (eflornithine): efficacy and tolerance in 14 cases in Côte d'Ivoire by Doua, F, Boa, F Y, Schechter, P J, Miézan, T W, Diai, D, Sanon, S R, De Raadt, P, Haegele, K D, Sjoerdsma, A, Konian, K

    “…alpha-Difluoromethylornithine (DFMO; eflornithine), an inhibitor of polyamine biosynthesis, was used to treat 14 patients with late stage gambiense sleeping…”
    Get more information
    Journal Article
  14. 14

    Selectivity of MDL 72,974A for MAO-B inhibition based on substrate and metabolite concentrations in plasma by Huebert, N D, Schwach, V, Hinze, C, Haegele, K D

    Published in Progress in brain research (1995)
    “…Plasma concentrations of 3,4-dihydroxyphenylethylglycol (DOPEG), noradrenaline (NA), adrenaline (A), 3,4-dihydroxyphenylalanine (DOPA),…”
    Get more information
    Journal Article
  15. 15

    Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy by Menachem, E B, Persson, L I, Schechter, P J, Haegele, K D, Huebert, N, Hardenberg, J, Dahlgren, L, Mumford, J P

    Published in Epilepsy research (01-03-1988)
    “…Vigabatrin, as a single oral dose of 50 mg/kg, was administered to 11 patients with drug-refractory complex partial epilepsy. Serial lumbar punctures were…”
    Get more information
    Journal Article
  16. 16

    Kinetics and metabolism of p-tyramine during monoamine oxidase inhibition by mofegiline by Huebert, N D, Dulery, B D, Schoun, J, Schwach, V, Hinze, C, Haegele, K D

    Published in Clinical pharmacology and therapeutics (01-11-1994)
    “…The effects of monoamine oxidase B (MAO-B) inhibition by mofegiline on the pharmacokinetics of p-tyramine and its major metabolite, p-hydroxyphenylacetic acid,…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo:: Importance of drug ionisation in the in vitro prediction of in vivo absorption by Boisset, Michel, Botham, Roger P., Haegele, Klaus D., Lenfant, Bernard, Pachot, Jean I.

    “…The aims of this study were (i) to compare the absorption of three closely related inhibitors of angiotensin II, RU60018, RU60079 and HR720, in various in…”
    Get full text
    Journal Article
  19. 19

    Determination of an acetylcholinesterase inhibitor, MDL 73745, in dog plasma and urine by combined gas chromatography/negative ion chemical ionization mass spectrometry by Dulery, B D, Le Henanf, N, Dow, J, Haegele, K D

    Published in Biological mass spectrometry (01-07-1993)
    “…A highly sensitive and specific assay has been developed for the determination of MDL 73745 [2,2,2-trifluoro-1-(3-trimethylsilyl-phenyl) ethanone] (I) and the…”
    Get more information
    Journal Article
  20. 20

    GABA differentially regulates the gene expression of proopiomelanocortin in rat intermediate and anterior pituitary by Loeffler, J P, Demeneix, B A, Pittius, C W, Kley, N, Haegele, K D, Höllt, V

    Published in Peptides (New York, N.Y. : 1980) (01-03-1986)
    “…The GABAergic regulation of proopiomelanocortin messenger RNA (POMC mRNA) levels in rat pituitary was investigated using molecular hybridization of DNA…”
    Get more information
    Journal Article